Aktie A2JJ8B CORLINE BIOMEDICAL AB
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Corline Biomedical AB

Aktien

A2JJ8B

SE0006887451

CLBIO

Markt geschlossen - Nasdaq Stockholm
Andere Börsenplätze
 13:36:26 15.05.2024 		% 5 Tage % 1. Jan.
10,1 SEK 0,00 % Intraday Chart für Corline Biomedical AB +0,50 % -32,21 %
30.04. Corline Biomedical AB meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI
14.02. Corline Biomedical AB meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2024
Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2023
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Corline Biomedical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2023
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2022
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Corline Biomedical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2022
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Corline Biomedical AB Reports Earnings Results for the Second Quarter Ended June 30, 2021
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2021
Corline Biomedical AB announced that it has received SEK 35.475 million in funding from M2 Asset Management AB, HealthInvest Partners AB, and other investors
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2020
Corline Biomedical AB to Enter into Agreement with the Clinical Islet Transplant Program at University of Alberta
Corline Biomedical AB to Enter into Agreement with Nuffield Department of Surgical Sciences
Corline Biomedical AB has completed an IPO in the amount of SEK 12.04 million.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2JJ8B Aktie
  4. Nachrichten Corline Biomedical AB
  5. Andere Sprachen